Audio Interview: Understanding the Omicron Variant of SARS-CoV-2

N Engl J Med. 2022 Feb 24;386(8):e27. doi: 10.1056/NEJMe2202699.
No abstract available

Publication types

  • Biography
  • Editorial
  • Historical Article
  • Interview
  • Webcast

MeSH terms

  • Animals
  • Antibodies, Viral / blood
  • COVID-19 Serological Testing*
  • COVID-19 Vaccines
  • COVID-19* / epidemiology
  • COVID-19* / immunology
  • COVID-19* / transmission
  • COVID-19* / virology
  • Disease Models, Animal
  • Disease Outbreaks
  • Endemic Diseases
  • Evolution, Molecular
  • History, 21st Century
  • Humans
  • Mutation*
  • Public Health / history
  • SARS-CoV-2 / genetics
  • SARS-CoV-2 / pathogenicity*
  • SARS-CoV-2 / physiology
  • Severity of Illness Index*
  • South Africa / epidemiology
  • Spike Glycoprotein, Coronavirus / immunology*
  • Virulence

Substances

  • Antibodies, Viral
  • COVID-19 Vaccines
  • Spike Glycoprotein, Coronavirus
  • spike protein, SARS-CoV-2

Supplementary concepts

  • SARS-CoV-2 variants

Personal name as subject

  • Paul Farmer